Status | Study |
Completed |
Study Name: Effects of Corticotropin Releasing Hormone (CRH) on the Sleep in Patients With Hypopituitarism Condition: Hypopituitarism Date: 2008-04-22 Interventions: Other: corticotropin releasing hormone (CRH) |
Completed |
Study Name: Oestrogen Withdrawal in Hypopituitary Women Condition: Hypopituitarism Date: 2007-12-11 Interventions: Drug: oestrogen Cyclic oestrogen substitution therapy |
Completed |
Study Name: Pituitary Functions After Traumatic Brain Injury (TBI) and/or Subarachnoid Hemorrhage (SAH) Condition: Traumatic Brain Injury Subarachnoid Hemorrhage Date: 2007-07-24 |
Recruiting |
Study Name: Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant Recipients Condition: Hypopituitarism Hypogonadism Date: 2007-07-18 |
Completed |
Study Name: Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone Deficiency Condition: Hypopituitarism Date: 2007-06-20 Interventions: Drug: Somatropin |
Completed |
Study Name: Effect of 5 Years of GH Replacement on Atherosclerosis Condition: Hypopituitarism Pituitary Tumors Date: 2007-04-18 Interventions: Drug: Recombinant Growth Hormone, Genotropin (Pfizer) |
Completed |
Study Name: Hypopituitarism Following Traumatic Brain Injury or Spontaneous Subarachnoidal Haemorrhages Condition: Brain Injuries Intracranial Aneurysm Date: 2007-02-13 |
Completed |
Study Name: Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation Condition: Secondary Hypothyroidism Hypopituitarism Date: 2006-08-02 Interventions: Drug: Thyroxin, Triiodothyronine |
Withdrawn |
Study Name: Baseline Sexual Function, Cognitive Function, Body Composition and Muscle Parameters and Pharmacokinetics of Transdermal Testosterone Gel in Women With Hypopituitarism Condition: Panhypopituitarism Date: 2005-09-01 |
Completed |
Study Name: Testosterone Gel Applied to Women With Pituitary Gland Problems Condition: Panhypopituitarism Date: 2005-09-01 Interventions: Drug: Transdermal Testosterone gel 2.0 mg per pump of transdermal testosterone gel. Study patients recei |